Research programme: mRNA cancer vaccines - Arcturus Therapeutics/Achilles Therapeutics
Alternative Names: Personalised mRNA cancer vaccines - Arcturus Therapeutics/Achilles TherapeuticsLatest Information Update: 11 Jun 2024
At a glance
- Originator Achilles Therapeutics; Arcturus Therapeutics
- Class Antineoplastics; Cancer vaccines; Immunotherapies; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer